Intralaryngeal injections of botulinum toxin (Botox), under electromyographic guidance, have emerged as an effective treatment for adductor spasmodic dysphonia. To remain effective, these injections must be repeated every 3 to 9 months as the symptoms recur. One drawback to the current method is the need for electromyographic confirmation of needle placement into the thyroarytenoid muscle. This report describes an anatomic approach to Botox injection that requires only flexible nasopharyngeal endoscopy and careful evaluation of the anatomic landmarks. This technique has been used successfully on 13 patients, and objective pretreatment and posttreatment measures are reported.
TraubeL.Spastishe Form der Nervousen Helserkeit. In: Gesammelte zur Pathologie und Physiologie. Vol 2. Berlin: Hirschwald, 1871.
2.
BlitzerALovelaceREBrinMFFahnSFinkME. Electromyographic findings in focal laryngeal dystonia (spastic dysphonia). Ann Otol Rhinol Laryngol1985; 94: 591–4.
3.
DedoHH. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol1976; 85: 451–9.
4.
IzdebskiKDedoHHShippTFlowerRM. Postoperative and follow-up studies of spastic dysphonia patients treated by recurrent laryngeal nerve section. Otolaryngol Head Neck Surg1981; 89: 96–101.
5.
AronsonAEDeSantoLW. Adductor spastic dysphonia: Three years after recurrent laryngeal nerve section. Laryngoscope1983; 93: 1–8.
6.
BillerHFSomMLLawsonW.Laryngeal nerve crush for spastic dysphonia. Ann Otol Rhinol Laryngol1979; 88: 531–2.
7.
BillerHFSomMLLawsonW.Laryngeal nerve crush for spastic dysphonia. Ann Otol Rhinol Laryngol1983;92–469.
8.
BlitzerABrinMFFahnSLangeDLovelaceRE. Letter to the editor. Laryngoscope1986; 96: 1300–1.
9.
BlitzerABrinMFFahnSLovelaceRE. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope1988; 98: 193–7.
10.
LudlowCLNauntonRFFujitaMSedorySE. Spasmodic dysphonia: Botulinum toxin injection after recurrent nerve surgery. Otolaryngol Head Neck Surg1990; 102: 122–31.
11.
FordCNBlessDMLoweryJD. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia. Otolaryngol Head Neck Surg1990; 103: 752–8.
12.
SeifertA.Perkutane Paraffininjektion zur Beseitigung der Folgen Einseitiger Stimmgandlaehmung. Z Laryngol Rhinol Otol Ihre Grenzgeb1916; 8: 233–5.
13.
WardPHHansonDGAbemayorE.Transcutaneous Teflon injection of the paralyzed vocal cord: A new technique. Laryngoscope1985; 95: 644–9.
14.
HiranoMTanakaSTanakaYHibiS.Transcutaneous intrafold injection for unilateral vocal fold paralysis: Functional results. Ann Otol Rhinol Laryngol1990; 99: 598–604.
15.
KoufmanJA. Laryngoplasty for vocal cord medialization: An alternative to Teflon. Laryngoscope1986; 96: 726–31.
16.
SmitheranJRHixonTJ. A clinical method for estimating laryngeal airway resistance during vowel production. J Speech Hear Disord1981; 46: 138–46.
17.
NetsellRLottsWDuchaneASBarlowSM. Vocal tract aerodynamics during syllable production: Normative data and theoretical implications. J Voice1991; 5: 1–9.
18.
GreenDCBerkeGS. An in vivo canine model for testing treatment effects in laryngeal hyperadduction disorders. Laryngoscope1990; 100: 1229–35.
19.
MillerRHWoodsonGEJankovicJ., Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report. Arch Otolaryngol Head Neck Surg1987; 113: 603–5.
20.
BrinMFBlitzerAFahnSGouldWLovelaceRE. Adductor laryngeal dystonia (spastic dysphonia): Treatment with local injections of botulinum toxin (Botox). Movement Disord1989; 4: 287–96.
21.
CarpenterRJIIISnyderGGIIIHenley-CohnJL. Selective section of the recurrent laryngeal nerve for the treatment of spastic dysphonia: An experimental study and preliminary clinical report. Otolaryngol Head Neck Surg1981; 89: 986–91.
